ME

23andMe (ME)

23andMe Holding Company

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ME

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/22	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/22	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/14	20:00	GlobeNewswire Inc.	Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals	NASDAQ:ME	23andMe Holding Company
2024/05/11	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/10	05:50	GlobeNewswire Inc.	23andMe to Report Q4 and Full Year FY2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/05/01	00:00	Business Wire	Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case	NASDAQ:ME	23andMe Holding Company
2024/04/25	05:05	GlobeNewswire Inc.	23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:ME	23andMe Holding Company
2024/04/18	21:00	GlobeNewswire Inc.	23andMe announces CEO’s intention to pursue a potential take-private	NASDAQ:ME	23andMe Holding Company
2024/04/06	05:05	GlobeNewswire Inc.	23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ME	23andMe Holding Company
2024/03/20	20:30	GlobeNewswire Inc.	23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6	NASDAQ:ME	23andMe Holding Company
2024/03/19	21:00	GlobeNewswire Inc.	23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago	NASDAQ:ME	23andMe Holding Company
2024/03/06	21:30	GlobeNewswire Inc.	23andMe Launches New Genetic Reports on Common Forms of Cancer	NASDAQ:ME	23andMe Holding Company
2024/03/06	06:30	GlobeNewswire Inc.	23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ME	23andMe Holding Company
2024/02/22	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/02/08	06:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ME	23andMe Holding Company
2024/02/08	06:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/02/08	06:01	GlobeNewswire Inc.	23andMe Reports Third Quarter Fiscal 2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/02/06	21:00	Business Wire	Moneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc.	NASDAQ:ME	23andMe Holding Company
2024/01/31	21:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/01/31	12:12	GlobeNewswire Inc.	23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay	NASDAQ:ME	23andMe Holding Company
2024/01/31	07:00	Business Wire	Nighthawk Gold Obtains Final Court Order for the Proposed Arrangement	NASDAQ:ME	23andMe Holding Company
2024/01/25	06:05	GlobeNewswire Inc.	23andMe to Report FY2024 Third Quarter Financial Results	NASDAQ:ME	23andMe Holding Company
2024/01/22	22:00	Business Wire	Moneta Gold and Nighthawk Gold Announce the Proposed Directors for the MergeCo Board	NASDAQ:ME	23andMe Holding Company
2024/01/08	21:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2023/12/19	22:00	GlobeNewswire Inc.	23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts	NASDAQ:ME	23andMe Holding Company
2023/12/02	06:06	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ME	23andMe Holding Company
2023/11/28	21:15	Business Wire	Nighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development Company	NASDAQ:ME	23andMe Holding Company
2023/11/22	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2023/11/22	06:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2023/11/14	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company